Description: China Medicine Corporation is a pharmaceutical company. The Company is engaged in the production and distribution of prescription and over the counter (OTC) drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The Company is developing a number of products for a range of indications, including oncology, high blood pressure and the removal of toxins from food and animal feeds. The Company's products include Shuangdan Capsules, Houerhuan Anti-inflammatory Capsules, Shugan Yipi Granules, Danggui Tiaojing Granules, Huangzao Granules, Pingfeng Shengmai Capsules, Danqi Tablets and Naodesheng Tablets. The Company also offers a range of dietary supplements, which include BeThin Tablets, Refrelizer Herbal Tea, LifeFull Herbal Tea and Relaxetox Herbal Tea. Shuangdan Capsules are indicated for the treatment of stagnation of the heart blood, obstruction of qi in the chest and cardiodynia.
Home Page: www.cmc621.com/cmc/index.php
2/F, Guangri Tower
Guangzhou,
510006
China
Phone:
86 20 8739 1718
Officers
| Name | Title |
|---|---|
| Mr. Senshan Yang | Chairman, CEO & Chairman of Guangzhou Konzern Medicine Co., Ltd |
| Mr. Ho Chi Fung | Chief Financial Officer |
| Ms. Huizhen Yu | Controller |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.0733 |
| Price-to-Sales TTM: | 0.0043 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 281 |